tamrintamab pamozirine (SC-003) / AbbVie  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
tamrintamab pamozirine (SC-003) / AbbVie
NCT02539719: Study of SC-003 Alone and in Combination With ABBV-181 in Subjects With Platinum-Resistant/Refractory Ovarian Cancer

Not Appicable Aug 2018 - Dec 2018 : For ovarian cancer (trial terminated)
Terminated
1a/1b
74
US
SC-003, SC-003 in combination with ABBV-181
Stemcentrx
Ovarian Cancer
01/19
01/19

Download Options